Andrx Not For Sale, New CEO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Andrx is not for sale despite a change in top-level management, new CEO Thomas Rice says
You may also be interested in...
Andrx Drops Cardura XL Distribution Deal In Move Away From Brand Business
Company moves to terminate a supply and distribution deal with Pfizer because the BPH agent failed to receive FDA approval by Dec. 31, 2004. Andrx is divesting its brand business to focus on its "core competencies" of controlled-release formulation development and distribution.
Andrx Drops Cardura XL Distribution Deal In Move Away From Brand Business
Company moves to terminate a supply and distribution deal with Pfizer because the BPH agent failed to receive FDA approval by Dec. 31, 2004. Andrx is divesting its brand business to focus on its "core competencies" of controlled-release formulation development and distribution.
Andrx Changes CEOs
Former Chesapeake Biological Laboratories President Thomas Rice is taking over as CEO of Andrx, effective immediately, the company announced Feb. 3